Inflammation in Urological Malignancies: The Silent Killer
Authors:
- Martina CatalanoMCMartina Catalano
- Giandomenico RovielloGiandomenico Roviello
- Raffaella SantiRSRaffaella Santi
- Donata VillariDVDonata Villari
- Pietro SpataforaPSPietro Spatafora
- Ilaria Camilla GalliIGIlaria Camilla Galli
- Francesco SessaFSFrancesco Sessa
- Francesco Lupo ConteFCFrancesco Lupo Conte
- Enrico MiniEnrico Mini
- Tommaso CaiTommaso Cai
- Gabriella NesiGabriella Nesi
Open Access
- 3 January 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 866
Abstract
Several studies have investigated the role of inflammation in promoting tumorigenesis and cancer progression. Neoplastic as well as surrounding stromal and inflammatory cells engage in well-orchestrated reciprocal interactions to establish an inflammatory tumor microenvironment. The tumor-associated inflammatory tissue is highly plastic, capable of continuously modifying its phenotypic and functional characteristics. Accumulating evidence suggests that chronic inflammation plays a critical role in the development of urological cancers. Here, we review the origins of inflammation in urothelial, prostatic, renal, testicular, and penile cancers, focusing on the mechanisms that drive tumor initiation, growth, progression, and metastasis. We also discuss how tumor-associated inflammatory tissue may be a diagnostic marker of clinically significant tumor progression risk and the target for future anti-cancer therapies.Keywords
This publication has 203 references indexed in Scilit:
- Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancersBMC Cancer, 2013
- Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 PathwayPLOS ONE, 2013
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder CancerPLOS ONE, 2013
- Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma CellsBioMed Research International, 2013
- Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancerJournal of Cancer Research and Clinical Oncology, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Aberrant PGE2 metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cellsInternational Immunopharmacology, 2011
- Retinoic acid receptor‐mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: Role of the renin‐angiotensin systemJournal of Cellular Physiology, 2010
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionCancer and Metastasis Reviews, 2010
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002